MR
Madhusudana Rao Kothapalli
About Madhusudana Rao Kothapalli
Data last updated:
Madhusudana Rao Kothapalli is a Director at Biophore India Pharmaceuticals Private Limited (since 2017), Designated Partner at Leiutis Pharmaceuticals Llp (since 2021) and Director at Vivere Imaging Private Limited (since 2020), and holds 1 more current directorship. The companies operate in Pharma, Real Estate and Construction and Information Technology. The 4 current companies with reported revenue have a combined latest revenue of ₹555 Cr; the largest is Biophore India Pharmaceuticals Private Limited at ₹457 Cr (FY 2025). Earlier, Madhusudana Rao Kothapalli was a Director at Apicore Pharmaceuticals Private Limited (2006–2014) and Director at Leiutis Pharmaceuticals Private Limited (2012–2021) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Biophore India Pharmaceuticals Private Limited U24232TG2007PTC053381 | Director | 15 Nov 2017 | 2007 | ₹457 Cr (FY 2025) | Active |
 Leiutis Pharmaceuticals Llp AAX-0501 | Designated Partner | 17 May 2021 | 2021 | ₹52.13 Cr (FY 2025) | Active |
 Vivere Imaging Private Limited U24230TG2020PTC139316 | Director | 18 Feb 2020 | 2020 | ₹45.31 Cr (FY 2025) | Active |
| Devaki Kanha Shanti Vanam U93000TG2010NPL067525 | Director | 12 Mar 2010 | 2010 | ₹13.2 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Apicore Pharmaceuticals Private Limited U24119GJ2006FTC048777 | Director | 27 Jul 2006 | 2006 | ₹195 Cr (FY 2024) | Active |
| Leiutis Pharmaceuticals Private Limited U73100AP2012PTC078351 | Director | 02 Jan 2012 | 2012 | ₹16.75 Cr (FY 2020) | Converted To Llp |
 Enixta Innovations Private Limited U72200TG2014PTC094559 | Director | 20 Jun 2014 | 2014 | ₹76.1 Lakh (FY 2024) | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Madhusudana Rao Kothapalli
| Name | DIN | Company | Designation |
|---|---|---|---|
| Harcharan Singh | 02852915 | Biophore India Pharmaceuticals Private Limited , Leiutis Pharmaceuticals Llp | Director |
| Jagadeesh Babu Rangisetty | 01725762 | Biophore India Pharmaceuticals Private Limited , Leiutis Pharmaceuticals Llp and 1 more | Managing Director |
| Manikreddy Pullagurla | 01850939 | Biophore India Pharmaceuticals Private Limited , Leiutis Pharmaceuticals Llp and 1 more | Director |
| Chandra Shekhar Kocherlakota | 05144398 | Leiutis Pharmaceuticals Llp | Designated Partner |
| Ramprasad Nimmagadda | 05182046 | Leiutis Pharmaceuticals Llp | Designated Partner |
| Vishnu Praveen Vempati | 06717201 | Vivere Imaging Private Limited | Ceo |
| Madhava Kumar Maram | 03137328 | Devaki Kanha Shanti Vanam | Director |
| Shyamsunder Mallick Vadlamani | 02665539 | Devaki Kanha Shanti Vanam | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Madhusudana Rao Kothapalli
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Madhusudana Rao Kothapalli
Madhusudana Rao Kothapalli currently holds 4 directorships: Biophore India Pharmaceuticals Private Limited (Director, since 15 Nov 2017, revenue ₹457 Cr (FY 2025)); Leiutis Pharmaceuticals Llp (Designated Partner, since 17 May 2021, revenue ₹52.13 Cr (FY 2025)); Vivere Imaging Private Limited (Director, since 18 Feb 2020, revenue ₹45.31 Cr (FY 2025)); Devaki Kanha Shanti Vanam (Director, since 12 Mar 2010, revenue ₹13.2 Lakh (FY 2025)).
Madhusudana Rao Kothapalli was first appointed on 27 Jul 2006 as Director at Apicore Pharmaceuticals Private Limited. The most recent appointment on record is 17 May 2021 at Leiutis Pharmaceuticals Llp.
The 4 current companies of Madhusudana Rao Kothapalli that report revenue have a combined latest revenue of ₹555 Cr: Biophore India Pharmaceuticals Private Limited ₹457 Cr (FY 2025); Leiutis Pharmaceuticals Llp ₹52.13 Cr (FY 2025); Vivere Imaging Private Limited ₹45.31 Cr (FY 2025); Devaki Kanha Shanti Vanam ₹13.2 Lakh (FY 2025).
Madhusudana Rao Kothapalli held 3 earlier board appointments: Apicore Pharmaceuticals Private Limited (Director, 27 Jul 2006 to 18 Dec 2014); Leiutis Pharmaceuticals Private Limited (Director, 02 Jan 2012 to 16 May 2021); Enixta Innovations Private Limited (Director, 20 Jun 2014 to 06 Mar 2021).
The current boards of Madhusudana Rao Kothapalli's companies include Harcharan Singh (Biophore India Pharmaceuticals Private Limited), Jagadeesh Babu Rangisetty (Biophore India Pharmaceuticals Private Limited), Manikreddy Pullagurla (Biophore India Pharmaceuticals Private Limited), Chandra Shekhar Kocherlakota (Leiutis Pharmaceuticals Llp), Ramprasad Nimmagadda (Leiutis Pharmaceuticals Llp), Vishnu Praveen Vempati (Vivere Imaging Private Limited), among others.